2022
DOI: 10.26434/chemrxiv-2022-3rhqf-v2
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Development of the first non-hydroxamate selective HDAC6 degraders

Abstract: The targeted degradation of histone deacetylase 6 (HDAC6) by heterobifunctional degraders constitutes a promising approach to treat HDAC6-driven diseases. Previous HDAC6 selective degraders utilised a hydroxamic acid as a zinc-binding group (ZBG) which features mutagenic and genotoxic potential. Here we report the development of a new class of selective HDAC6 degraders based on a difluoromethyl-1,3,4-oxadiazole warhead as ZBG.

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…51 In the same year, we successfully incorporated the DFMO warhead into proteolysis-targeting chimeras (PROTACs) to selectively degrade HDAC6. 52 However, the mechanism by which DFMOs inhibit or degrade HDAC6 remained enigmatic. In a conference abstract published in 2022, we disclosed that a https://doi.org/10.26434/chemrxiv-2023-6kt1w-v4 ORCID: https://orcid.org/0000-0001-9765-5975 Content not peer-reviewed by ChemRxiv.…”
Section: Introductionmentioning
confidence: 99%
“…51 In the same year, we successfully incorporated the DFMO warhead into proteolysis-targeting chimeras (PROTACs) to selectively degrade HDAC6. 52 However, the mechanism by which DFMOs inhibit or degrade HDAC6 remained enigmatic. In a conference abstract published in 2022, we disclosed that a https://doi.org/10.26434/chemrxiv-2023-6kt1w-v4 ORCID: https://orcid.org/0000-0001-9765-5975 Content not peer-reviewed by ChemRxiv.…”
Section: Introductionmentioning
confidence: 99%